| Date | Time | Source | Headline | Symbol | Company |
| 04/10/2014 | 8:00AM | Business Wire | Ironwood and Forest Launch New Direct-to-Consumer Awareness Campaign For LINZESS® | NYSE:FRX | Forest Road Acquisition Corp |
| 04/09/2014 | 10:14AM | PR Newswire (US) | Health Care Sector Stocks under Review -- Research on Endo Intl., Dynavax Technologies, Forest Laboratories, and Orexigen The... | NYSE:FRX | Forest Road Acquisition Corp |
| 04/09/2014 | 3:17AM | Business Wire | Forest Laboratories and Almirall Provide Update on the Fixed Dose Combination of Aclidinium and Formoterol in the U.S. | NYSE:FRX | Forest Road Acquisition Corp |
| 04/07/2014 | 8:00AM | PR Newswire (US) | Drug Recommendations, Legal Updates, Awards, Stock Price Movements, and Upcoming Results and Conference Call Schedules - Anal... | NYSE:FRX | Forest Road Acquisition Corp |
| 04/01/2014 | 8:00AM | Business Wire | Forest Laboratories, Inc. Sets Date and Conference Call for Fiscal 2014 Fourth Quarter Earnings | NYSE:FRX | Forest Road Acquisition Corp |
| 03/31/2014 | 9:18AM | Dow Jones News | U.S. Hot Stocks: Hot Stocks to Watch | NYSE:FRX | Forest Road Acquisition Corp |
| 03/31/2014 | 3:00AM | Business Wire | Forest Laboratories, Inc. & Gedeon Richter Plc. Announce Positive Phase IIb Topline Results for Cariprazine for the Treatment... | NYSE:FRX | Forest Road Acquisition Corp |
| 03/28/2014 | 3:44PM | Edgar (US Regulatory) | Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) | NYSE:FRX | Forest Road Acquisition Corp |
| 03/27/2014 | 3:49PM | Edgar (US Regulatory) | Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) | NYSE:FRX | Forest Road Acquisition Corp |
| 03/26/2014 | 2:17AM | Zacks | Pharma & Biotech Stock Outlook - March 2014 - Zacks Analyst Interviews | NYSE:FRX | Forest Road Acquisition Corp |
| 03/26/2014 | 2:17AM | Zacks | Pharma & Biotech Stock Outlook - March 2014 - Industry Outlook | NYSE:FRX | Forest Road Acquisition Corp |
| 03/21/2014 | 10:08AM | PR Newswire (US) | Health Car Sector Equities Technical Insight -- Research on Dynavax Technologies, Forest Laboratories, Orexigen Therapeutics ... | NYSE:FRX | Forest Road Acquisition Corp |
| 03/21/2014 | 3:00AM | Business Wire | Forest Laboratories, Inc. & Gedeon Richter Plc. Announce Positive Phase IIb Topline Results for Cariprazine as Adjunctive The... | NYSE:FRX | Forest Road Acquisition Corp |
| 03/20/2014 | 8:00AM | PR Newswire (US) | Healthcare Companies Report FDA Approvals, Comprehensive Analysis, Schedules, and Stock Movements - Analyst Notes on Pfizer, ... | NYSE:FRX | Forest Road Acquisition Corp |
| 03/13/2014 | 5:09PM | Edgar (US Regulatory) | Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) | NYSE:FRX | Forest Road Acquisition Corp |
| 03/12/2014 | 8:00AM | PR Newswire (US) | Collaborations, Treatment Approvals, New Solutions, Clinical Trial Results, and New Drug Applications - Analyst Notes on Biog... | NYSE:FRX | Forest Road Acquisition Corp |
| 03/07/2014 | 6:00PM | Zacks | Forest Labs/Adamas Seek FDA Approval - Analyst Blog | NYSE:FRX | Forest Road Acquisition Corp |
| 03/06/2014 | 8:25AM | PR Newswire (US) | Patient Support Programs, Financial Results, and Stock Price Movements - Analyst Notes on Gilead, Forest Laboratories, Thermo... | NYSE:FRX | Forest Road Acquisition Corp |
| 03/05/2014 | 5:27PM | Edgar (US Regulatory) | Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) | NYSE:FRX | Forest Road Acquisition Corp |
| 03/05/2014 | 12:21PM | PR Newswire (US) | Investor Alert: Pittsburgh Law Office of Alfred G. Yates, Jr., P.C. Announces Investigations into Carnival Corporation (NYSE:... | NYSE:FRX | Forest Road Acquisition Corp |
| 03/04/2014 | 8:00AM | Business Wire | Forest Laboratories & Adamas Pharmaceuticals Announce Forest’s Submission of New Drug Application for Memantine Extended Re... | NYSE:FRX | Forest Road Acquisition Corp |
| 02/27/2014 | 8:00AM | Business Wire | Forest Laboratories Submits a New Drug Application for Nebivolol and Valsartan Combination in Hypertension | NYSE:FRX | Forest Road Acquisition Corp |
| 02/25/2014 | 7:00PM | Zacks | Sanofi/Ardelyx Ink Deal - Analyst Blog | NYSE:FRX | Forest Road Acquisition Corp |
| 02/25/2014 | 7:20AM | Dow Jones News | TPG 'Contemplating' Going Public | NYSE:FRX | Forest Road Acquisition Corp |
| 02/24/2014 | 5:01PM | Dow Jones News | MARKET SNAPSHOT: Stocks Rally; S&P 500 Ends Right Below Record | NYSE:FRX | Forest Road Acquisition Corp |
| 02/24/2014 | 1:53PM | Dow Jones News | MARKET SNAPSHOT: U.S. Stocks Rally As S&P 500 Hits Intraday Record | NYSE:FRX | Forest Road Acquisition Corp |
| 02/24/2014 | 8:00AM | Business Wire | Forest Laboratories, Inc. Launches STRIDE Patient Support Program for COPD Franchise Products Tudorza® Pressair® & Daliresp® | NYSE:FRX | Forest Road Acquisition Corp |
| 02/24/2014 | 5:47AM | Dow Jones News | MARKET SNAPSHOT: U.S. Stock Market Is Starting To Ride A Tech M&A Wave | NYSE:FRX | Forest Road Acquisition Corp |
| 02/23/2014 | 8:16AM | Dow Jones News | MARKET SNAPSHOT: U.S. Stock Market Is Starting To Ride A Tech M&A Wave | NYSE:FRX | Forest Road Acquisition Corp |
| 02/21/2014 | 11:22AM | Business Wire | Law Firm Brower Piven Announces Investigation of Forest Laboratories, Inc. Proposed Buyout | NYSE:FRX | Forest Road Acquisition Corp |